|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net (loss) income | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of effects of assets acquired and liabilities assumed: | |||
| Depreciation, depletion, and amortization | |||
| Impairment of long-lived assets | |||
| Accretion of discount in asset retirement obligation | |||
| Derivative fair value (gain) loss | |||
| Net cash received from (paid to) counterparties | |||
| Non-cash gain on forgiveness of debt | |||
| Non-cash incentive compensation | |||
| Other non-cash items | |||
| Changes in operating assets and liabilities(a) | |||
| Cash Provided by Operating Activities | |||
| INVESTING ACTIVITIES | |||
| Proceeds from sale of property and equipment | |||
| Proved property acquisitions | |||
| Development costs | |||
| Unproved property acquisitions | |||
| Other property additions | |||
| Cash Used by Investing Activities | |||
| FINANCING ACTIVITIES | |||
| Proceeds from long-term debt | |||
| Payments on long-term debt | |||
| Exercise of Series 3 Warrants | |||
| Net proceeds from initial public offering | |||
| Proceeds from permanent equity investment | |||
| Net proceeds from public offering | |||
| Debt issuance costs | |||
| Capitalized offering costs | |||
| Proceeds from sale of units to cover withholding taxes | |||
| Withholding taxes paid on vesting of restricted units | |||
| Distributions | |||
| Cash Provided by (Used by) Financing Activities | |||
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||
| Cash and Cash Equivalents, beginning of period | |||
| Cash and Cash Equivalents, end of period | |||
| (a) Changes in Operating Assets and Liabilities | |||
| Accounts receivable | |||
| Other assets | |||
| Aid-in-construction asset | |||
| Current liabilities | |||
| Other operating liabilities |
Loading...
